MEDICAL DISCLAIMER: Educational research guidelines only. Lyophilized peptides are investigational chemical compounds and are NOT approved for human consumption, diagnosis, or therapy. Consult a licensed physician before any research application.
GHK-Cu Dosage Chart, Schedule & Reconstitution Protocol
Quickstart Highlights
GHK-Cu is the copper-binding tripeptide glycyl-L-histidyl-L-lysine complexed with divalent copper, first isolated from human plasma by Loren Pickart in 1973. Plasma concentrations decline with age, paralleling reductions in regenerative capacity. GHK-Cu functions as a physiological copper transporter that activates lysyl oxidase, superoxide dismutase, and other cuproenzymes, and at nanomolar concentrations it resets expression of more than four thousand human genes toward youthful patterns, including DNA repair, antioxidant defense, and extracellular matrix pathways [PMID: 30041975]. It is studied for wound healing, collagen and proteoglycan synthesis, hair follicle anagen prolongation, anti-inflammatory effects, and photoaging reversal [PMID: 7748800]. GHK-Cu is most commonly used topically at 0.05 to 2 percent in serums and scalp formulations; subcutaneous or intradermal injection is explored only in research contexts and is not standardized.
Reconstitute: Add 3 mL bacteriostatic water → 16.67 mg/mL concentration.
Typical dose: 1.0–2.0 mg per injection (most common protocols use 5 days/week or 3×/week).
Easy measuring: At 16.67 mg/mL, 1 unit = 0.01 mL = 0.167 mg (167 mcg) on a U-100 insulin syringe.
Storage: Lyophilized frozen; reconstituted refrigerated and used within 30 days.
Pickart's transcriptomic finding: Connectivity Map analysis shows GHK at 1 microMolar shifts expression of over 4,000 genes by 50 percent or more, including upregulation of TP53, FANCC, and decorin while modulating MMP and TIMP balance.
Topical vs injection trade-off: Topical use is well established and cosmetic-regulated; injection of GHK-Cu is off-label, unstandardized, and can produce localized blue-green skin staining from the copper chromophore itself, especially at higher concentrations.
Synergy with minoxidil: Small open-label androgenetic alopecia studies show modest increases in hair count, shaft diameter, and anagen phase duration, with effects most pronounced when GHK-Cu solutions are combined with topical minoxidil.
Quick Protocol Navigation
Reconstitution Instruction & Mixing Step-by-Step
Lyophilized powder must be reconstituted carefully. Agitating peptide chains can shear disulfide bonds and render the peptide biologically inert.
Draw 3.0 mL sterile or bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall to minimize foaming.
Gently swirl or roll the vial until the peptide fully dissolves (do not shake vigorously).
Inject slowly and steadily; withdraw needle at same angle as insertion.
Do not aspirate for subcutaneous injections; inject slowly and steadily[17].
Interactive GHK-Cu Syringe Calculator
Currently visualizing the 50 mg vial reconstituted with 3 mL bacteriostatic water. Adjust the target dose to dynamically render syringe units.
Reconstitution Calculation: 50mg dry powder in 3mL water yields 16.67 mg/mL. To evaluate a 250mcg dose, pull to 1.5 units (2 syringe ticks).
U-100 Syringe Representation
1.5 Units (2 Ticks)
Educational reference visual. Assumes standard U-100 insulin syringe where 1.0 mL volume = 100 units.
Titration & Dose Escalation Schedules
| Week/Phase | Dose per Injection | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–4 | 1.0 mg (1000 mcg) | 6 units (0.06 mL) |
| Weeks 5–8 | 1.5 mg (1500 mcg) | 9 units (0.09 mL) |
| Weeks 9–12+ | 2.0 mg (2000 mcg) | 12 units (0.12 mL) |
Administration guidelines: Refer to guidelines | 3 mL Reconstitution
| Week/Phase | Dose per Injection | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–12+ | 2.0 mg (2000 mcg) | 12 units (0.12 mL) |
Administration guidelines: Refer to guidelines | 3 mL Reconstitution
Research Supplies Quantity Planner
Scientific mathematical planning of syringes, bacteriostatic water and dry vials needed for extended research blocks using the 50 mg vial.
Peptide Vials (GHK-Cu, 50 mg each):
- check5 days/week (1.0–2.0 mg/day):
- check8 weeks (~50 mg total) ≈ 1 vial
- check12 weeks (~90 mg total) ≈ 2 vials
- check16 weeks (~130 mg total) ≈ 3 vials
- check3×/week (2 mg each):
- check8 weeks (~48 mg) ≈ 1 vial
- check12 weeks (~72 mg) ≈ 2 vials
- check16 weeks (~96 mg) ≈ 2 vials
Insulin Syringes (U‑100, 29–31 gauge):
- check5 days/week:
- checkPer week: 5 syringes
- check8 weeks: 40 syringes
- check12 weeks: 60 syringes
- check16 weeks: 80 syringes
- check3×/week:
- checkPer week: 3 syringes
- check8 weeks: 24 syringes
- check12 weeks: 36 syringes
- check16 weeks: 48 syringes
Sterile or Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
- check1 vial protocols: 3 mL → 1 × 10 mL bottle
- check2 vial protocols: 6 mL → 1 × 10 mL bottle
- check3 vial protocols: 9 mL → 1 × 10 mL bottle
Alcohol Swabs: One for the vial stopper + one for the injection site each administration.
- check5 days/week:
- checkPer week: 10 swabs (2 per injection)
- check8 weeks: 80 swabs → recommend 1 × 100‑count box
- check12 weeks: 120 swabs → recommend 2 × 100‑count boxes
- check16 weeks: 160 swabs → recommend 2 × 100‑count boxes
- check3×/week:
- checkPer week: 6 swabs
- check8 weeks: 48 swabs → recommend 1 × 100‑count box
- check12 weeks: 72 swabs → recommend 1 × 100‑count box
- check16 weeks: 96 swabs → recommend 1 × 100‑count box
Mechanism of Action (MOA)
Glycyl-L-histidyl-L-lysine (GHK) is a tripeptide naturally present in human plasma, saliva, and urine. The molecule exhibits an exceptionally high affinity for copper (II) ions, forming a stable square-planar complex (GHK-Cu) in which copper is coordinated by the histidine imidazole nitrogen, the deprotonated amide nitrogen of the histidyl-lysine peptide bond, and the alpha-amino group of glycine. Plasma GHK concentrations decline progressively with age, from approximately 200 ng/mL in young adults to 80 ng/mL by the seventh decade, paralleling reductions in regenerative capacity, wound healing efficiency, and tissue copper homeostasis [1]. GHK-Cu exerts pleiotropic effects through several interrelated mechanisms. First, it functions as a physiological copper transporter, shuttling copper across cell membranes and delivering it to copper-dependent enzymes including superoxide dismutase 1 (antioxidant defense), lysyl oxidase (collagen and elastin crosslinking), cytochrome c oxidase (mitochondrial energy production), tyrosinase (melanin synthesis), and dopamine-beta-hydroxylase. Activation of these enzymes underlies many of the regenerative effects observed in skin, hair follicles, and connective tissues [2]. Second, GHK-Cu directly modulates gene expression. Transcriptomic studies using the Connectivity Map demonstrate that GHK at concentrations as low as 1 microMolar resets the expression of more than four thousand human genes by an average of fifty percent or more, shifting profiles toward those of younger, healthier tissue [1]. Affected pathways include extracellular matrix remodeling, DNA repair (notably TP53 and FANCC), antioxidant defense, inflammation resolution, and neurotrophin signaling. In keloid scar fibroblasts, GHK-Cu downregulates pro-fibrotic gene expression and normalizes pathological scarring patterns. Third, GHK-Cu coordinates the inflammatory and proliferative phases of wound healing. It attracts macrophages, mast cells, and capillary endothelial cells to wound sites, stimulates angiogenesis through upregulation of vascular endothelial growth factor and basic fibroblast growth factor, and accelerates re-epithelialization. Maquart and colleagues demonstrated that GHK-Cu simultaneously stimulates synthesis of collagen, glycosaminoglycans, dermatan sulfate, chondroitin sulfate, and the small leucine-rich proteoglycan decorin while upregulating both matrix metalloproteinases (MMP-2) and their tissue inhibitors (TIMP-1, TIMP-2), enabling balanced extracellular matrix remodeling rather than indiscriminate degradation [3]. Fourth, in the hair follicle, GHK-Cu prolongs the anagen growth phase, enlarges follicle size, and stimulates dermal papilla proliferation. Topical formulations have been shown in small studies to increase hair count and shaft diameter in androgenetic alopecia, particularly when combined with minoxidil. Its molecular weight of 340 Da and balanced amphipathic character allow modest penetration through the stratum corneum, especially when formulated with appropriate vehicles. Clinically, GHK-Cu is used topically at concentrations of 0.05% to 2% in anti-aging serums, post-procedure recovery creams, and hair-loss formulations, applied once or twice daily. Injectable subcutaneous or intradermal use is occasionally explored in research settings at doses of 1–2 mg, but is not standardized and carries the risk of localized blue-green pigmentation due to the inherent color of the copper complex.
Clinical Trial Efficacy Highlights
- starPickart and Margolina's comprehensive 2018 review in International Journal of Molecular Sciences synthesized over four decades of GHK-Cu research and documented its role in resetting expression of more than four thousand human genes toward youthful patterns, including upregulation of DNA repair, antioxidant defense, and extracellular matrix synthesis pathways relevant to aged or photodamaged skin [1].
- starMaquart, Pickart and colleagues demonstrated in cultured fibroblasts and in vivo wound models that GHK-Cu stimulates synthesis of collagen, glycosaminoglycans, dermatan sulfate, chondroitin sulfate, and the proteoglycan decorin while simultaneously modulating expression of matrix metalloproteinases and their inhibitors, supporting balanced extracellular matrix remodeling rather than excessive degradation or fibrosis [3].
- starA facial-wrinkle clinical study by Leyden and colleagues comparing a 0.1% GHK-Cu cream with vitamin C and vehicle controls reported significant improvements in fine line depth, skin density on ultrasound, and clinical wrinkle scores after twelve weeks of twice-daily application, with tolerability comparable to vehicle [4].
- starIn small open-label studies of androgenetic alopecia, topical GHK-Cu solutions used twice daily for several months produced increases in hair count and shaft diameter and prolonged the anagen phase, particularly when combined with minoxidil; effect sizes are modest but support adjunctive use in early hair-loss management [5].
- starA randomized controlled trial in patients with chronic non-healing diabetic foot ulcers found that GHK-Cu-containing wound dressings accelerated re-epithelialization and granulation tissue formation compared with standard care, consistent with the peptide's documented chemotactic and angiogenic effects [3].
- starMechanistic studies show that GHK-Cu suppresses tumor necrosis factor-alpha and interleukin-6 in keratinocyte cultures, promotes M2 macrophage polarization, and shifts wound microenvironments from chronic inflammation toward resolution, helping explain its efficacy in difficult-to-heal wounds and post-procedure recovery protocols [2].
- starIn photoaged skin models, GHK-Cu reduces ultraviolet-induced reactive oxygen species generation, enhances superoxide dismutase activity, and limits matrix metalloproteinase-1 upregulation, mechanistically supporting its widespread use in topical anti-aging serums and post-laser recovery formulations [1].
Side Effects & Tolerability Profile
Clinical subjects transiently report mild side effects. Slowly escalating the titration dose represents the single most effective intervention to limit side effects.
- warningTopical GHK-Cu is exceptionally well tolerated. The most common adverse event is mild, transient erythema or stinging at the application site, particularly when used on freshly resurfaced or compromised skin barriers.
- warningThe copper-tripeptide complex has an intrinsic blue-green color that can transiently tint skin, hair, and fabrics, particularly with high-concentration serums; this discoloration is cosmetic and washes off easily with cleansing.
- warningAllergic contact dermatitis to GHK-Cu is rare but possible, especially in individuals with known copper sensitivity; patch testing is recommended for users with a history of metal allergy or persistent dermatitis.
- warningSubcutaneous or intradermal injection in research settings can produce localized blue-green pigmentation, mild swelling, bruising, or pain at the injection site, and the long-term safety of injectable GHK-Cu has not been characterized in formal trials.
- warningExcessive systemic copper exposure is theoretically possible with very high topical doses on broken skin or with injectable use; signs of copper excess (nausea, abdominal discomfort, metallic taste) have not been documented at standard cosmetic concentrations.
- warningSafety data in pregnancy and lactation are limited; while topical exposure is unlikely to produce systemic effects, manufacturers generally advise avoiding GHK-Cu products during these periods on a precautionary basis.
- warningGHK-Cu should not be combined directly with high-concentration vitamin C (ascorbic acid) on the skin at the same moment, since copper can catalyze ascorbate oxidation and reduce the efficacy of both actives; alternating morning and evening use avoids this interaction.
Subcutaneous Injection Technique
Most research peptides require subcutaneous injection into fatty tissue. Never inject directly into a blood vessel or deep muscle tissue unless clinically detailed.
1. Site Selection
Common locations include the abdomen (2 inches from navel), outer upper arms, or thighs.
2. Sanitization
Thoroughly clean the selected site, stopper and vial top using 70% isopropyl alcohol prep swabs.
3. Angle & Push
Pinch the skin and insert the needle at a 45 to 90-degree angle. Depress plunger smoothly.
4. Site Rotation
Rotate injection sites continuously to avoid lipodystrophy or tissue scarring.
Frequently Asked Questions
What is the typical GHK-Cu dosage?expand_more
Topical GHK-Cu is most commonly formulated at 0.05% to 2% in serums and creams, applied once or twice daily to clean skin. Hair-loss formulations use similar concentrations applied to the scalp. Injectable research protocols use 1–2 mg subcutaneously, but no standardized clinical injectable dose exists.
How is GHK-Cu administered?expand_more
GHK-Cu is primarily applied topically as a leave-on serum, cream, or scalp solution. After cleansing, a small amount is gently massaged into target areas and followed by moisturizer and sunscreen. Research subcutaneous injection in the abdomen is occasionally explored but is not a standardized clinical route.
Can GHK-Cu be combined with other compounds?expand_more
GHK-Cu pairs well with retinoids, niacinamide, hyaluronic acid, peptides such as Matrixyl, and growth factors. Avoid simultaneous application with high-concentration vitamin C, since copper can catalyze ascorbate oxidation; alternate morning and evening use instead.
What are the side effects of GHK-Cu?expand_more
Topical use is very well tolerated. Mild stinging, transient erythema, and occasional blue-green tinting of skin or fabrics from the copper complex are the most frequent observations. Allergic contact dermatitis is rare but possible in copper-sensitive individuals.
Is GHK-Cu FDA approved?expand_more
GHK-Cu is not an FDA-approved drug. It is regulated as a cosmetic ingredient in the United States and European Union and is widely used in over-the-counter anti-aging skincare. Injectable GHK-Cu is unapproved and exists only in research and compounding contexts.
Academic References & Study Citations
Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. View Scientific Paper →
Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. View Scientific Paper →
Simeon A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+). J Invest Dermatol. 2000;115(6):962-968. View Scientific Paper →
Leyden J, Stephens T, Finkey M, et al. Skin care benefits of copper peptide containing facial cream. Am Acad Dermatol Meeting. 2002. View Scientific Paper →
Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Oxid Med Cell Longev. 2012;2012:324832. View Scientific Paper →
Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-346. View Scientific Paper →
Trumbore MW, Lerner D, Lambrechts J, et al. Anti-inflammatory and tissue-protective effects of GHK-Cu in inflammatory skin models. Exp Dermatol. 2014. View Scientific Paper →
Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. View Scientific Paper →
Hostynek JJ, Dreher F, Maibach HI. Human stratum corneum penetration by copper: in vivo study after occlusive and semi-occlusive application of the metal as powder. Food Chem Toxicol. 2006;44(9):1539-1543. View Scientific Paper →
Choi HR, Kang YA, Ryoo SJ, et al. Stem cell recovering effect of copper-free GHK in skin. J Pept Sci. 2012;18(11):685-690. View Scientific Paper →